Preterm birth is still a huge problem in modern obstetrics. Because the stakes are so high,
physicians and parents are understandably anxious to do anything possible to prevent …

Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …

Objective The objective is to provide guidelines for the use of antenatal magnesium sulphate
for fetal neuroprotection of the preterm infant. Options Antenatal magnesium sulphate …

Available evidence now suggests that magnesium sulfate administered to mothers prior to
early preterm delivery reduces the risk of cerebral palsy in surviving neonates. The …

Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …

METHODS OF STUDY SELECTION: Randomized controlled trials comparing magnesium
sulfate with placebo/other treatment in patients at risk of preterm delivery were evaluated for …

Some observational studies show that, in very preterm births, magnesium sulfate treatment
is associated with a lower risk of intraventricular hemorrhage (IVH), which predisposes to …

Prematurity remains a proximate cause of infant morbidity and mortality. 1 Despite extensive
years of research and investment, limited gains have been made in preventing preterm birth …

Background Research suggests that fetal exposure to magnesium sulfate before preterm
birth might reduce the risk of cerebral palsy. Methods In this multicenter, placebo-controlled …

Magnesium sulfate administered intravenously to women at risk for early preterm birth can
decrease risk of cerebral palsy in their babies. The regime from one of the larger …